medigraphic.com
ISSN 2539-0859 (Electronic)
ISSN 0120-8411 (Print)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)

2022, Number 1

<< Back Next >>

Acta de Otorrinolaringología CCC 2022; 50 (1)

Diagnosis and treatment of chronic rhinosinusitis in adults. Expert consensus: Asociación Colombiana de Otorrinolaringología -2021

Silva-Rueda R, Ospina JA, Bedoya JD, Mora-Díaz C, Castro CA, Sánchez-Vanegas G, Herrera AJ, Villamizar-Rubio JR, Melo JE, Delgado SNA, Cardozo TMD, Duarte JP, Santa CAM, Vergara HJC, Jaraba PRA, Pinzón MA, Campuzano HC, Fajardo RJA, Cobo-Sefair R

Language: Spanish
References: 35
Page: 28-35
PDF size: 285.48 Kb.


ABSTRACT

Introduction: Chronic Rhinosinusitis is defined as chronic inflammation of the nose and paranasal sinuses for more than 12 weeks. The prevalence varies between 5% - 30% depending on the geographical area according to a disease burden study (2012-2014), the prevalence of chronic respiratory diseases (rhinitis and chronic sinusitis) varied between 10% - 25%. Objective: To establish a set of considerations based on expert consensus, for the diagnosis and treatment of chronic rhinosinusitis in adult patients, in the Colombian context. Methods: A formal consensus (Delphi and nominal) was carried out. A group of experts was formed, the scope and questions were defined. Two anonymous grading rounds were conducted, and a discussion for questions without consensus. In the Questions with options from one to nine were considered consensus with a median of one to three or seven to nine. In the Likert-type questions, a percentage equal to or greater than 80% in agreements or disagreements was considered consensus. Results: 18 questions were defined and scored, with the participation of 17 otorhinolaryngologists, from eight Colombian cities, all members of the Colombian Association of Otorhinolaryngology and with an average experience of 19.2 years (Standard desviation [SD]: 10.2). 18 recommendations were obtained for the diagnosis and treatment of this pathology. Conclusions: The recommendations issued by the experts allow to guide and standardize the diagnosis and treatment of chronic rhinosinusitis in adults, in the context of health services in Colombia.


REFERENCES

  1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R,Reitsma S, et al. European Position Paper on Rhinosinusitis andNasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. doi:10.4193/Rhin20.600

  2. Alvo A, Barahona L, Aranibar H, Gianini R. Rinosinusitiscrónica: una revisión de su etiopatogenia. Rev OtorrinolaringolCir Cabeza Cuello. 2018;78(4):451-62.

  3. Morbi-mortalidad de las enfermedades respiratorias crónicas,Colombia 2005-2013 [Internet]. Minsalud; 2015 [Acceso2021]. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/morbimortalidadenfer-resp-cronica-2017.pdf

  4. Silva R, Parra DP, García LE. Factores pronósticos para cirugíaendoscópica funcional en rinosinusitis crónica: una revisión dela literatura actual. Revista Med. 2011;19(2):232-40.

  5. Muñoz-Carlin ML, Nevárez-Sida A, García-Contreras F,Mendieta-Sevilla SR, Constantino-Casas P. Costo-efectividaddel tratamiento de rinosinusitis aguda y crónica en el IMSS.Rev Invest Clin. 2007;59(3):197-205.

  6. Hamilos DL, EH H. Chronic rhinosinusitis: Management[Internet]. UpToDay; 2021 [Acceso 2021]. Disponible en:https://www.uptodate.com/contents/chronic-rhinosinusitismanagement?search=Chronic%20rhinosinusitis:%20Management%20&source=search_result&selectedTitle=2~145&usage_type=default&display_rank=2

  7. Marrugo G, Rodríguez P. Guía para el diagnóstico derinosinusitis del adulto [Internet]. ACORL; 2016 [Acceso:2021]. Disponible en: https://www.acorl.org.co/resources/imagenes/visitante/medico/apoyo-al-ejercicio-profesional/guias-acorl/GUIAS_ACORL_Sinusitis_en_el_adulto.pdf

  8. Vargas Duque R, Milanés Pérez R, Carmona Meza Z. Factoresambientales asociados a Rinosinusitis crónica. HospitalUniversitario del Caribe, Cartagena (Colombia). SaludUninorte. 2018;34(3):727-36.

  9. Rot P, Rapiejko P, Jurkiewicz D. Intranasal steroid therapy- EPOS 2020. Otolaryngol Pol. 2020;74(3):41-49. doi:

  10. 10.5604/01.3001.0014.244910. Borish L, Baroody FM, Kim MS, Lieberman JA, Peters A,Stevens WW, et al. Yardstick for the medical managementof chronic rhinosinusitis. Ann Allergy Asthma Immunol.2022;128(2):118-128. doi: 10.1016/j.anai.2021.10.014

  11. Chong L-Y, Piromchai P, Sharp S, Snidvongs K, Webster KE,Philpott C, et al. Biologics for chronic rhinosinusitis. Cochrane;2021 [Acceso: 2021]. Disponible en: https://www.cochrane.org/es/CD013513/ENT_productos-biologicos-para-personascon-rinosinusitis-cronica

  12. Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ,Hicks LA, et al. IDSA clinical practice guideline for acutebacterial rhinosinusitis in children and adults. Clin Infect Dis.2012;54(8):e72-e112. doi: 10.1093/cid/cir1043

  13. Meltzer EO, Hamilos DL. Rhinosinusitis diagnosis andmanagement for the clinician: a synopsis of recent consensusguidelines. Mayo Clin Proc. 2011;86(5):427-43. doi: 10.4065/mcp.2010.0392

  14. De Vilhena D, Duarte D, Lopes G. Calidad de vida en larinosinusitis crónica con poliposis nasal. Revista ORL.2016;7(1):17-22. doi: 10.14201/orl.13527

  15. Malaty J. Medical Management of Chronic Rhinosinusitisin Adults. Sinusitis. 2016;1(1):76-87. doi: 10.3390/sinusitis1010076

  16. Head K, Sharp S, Chong LY, Hopkins C, Philpott C. Topicaland systemic antifungal therapy for chronic rhinosinusitis.Cochrane Database Syst Rev. 2018;9(9):CD012453. doi:10.1002/14651858.CD012453.pub2

  17. Valdés PC, Muñoz MT, Barría ET, Bogado BM, Ruz MP,Cardemil MF, et al. Validación de encuesta de calidad devida SNOT-22 en población chilena. Rev OtorrinolaringolCir Cabeza Cuello. 2020;80(4):425-33. doi: 10.4067/S0718-48162020000400425

  18. Chi-Cauich IK, Castañeda-De León MR. Prueba SNOT-22para valorar mejoría clínica en cirugía rinosinusal. An Orl Mex.2021;66(2):104-9. doi: 10.24245/aorl.v66i2.4437

  19. Arndal E, Sorensen AL, Lapperre TS, Said N, Trampedach C,Aanæs K, et al. Chronic rhinosinusitis in COPD: A prevalentbut unrecognized comorbidity impacting health relatedquality of life. Respir Med. 2020;171:106092. doi: 10.1016/j.rmed.2020.106092

  20. Bayar Muluk N, Cingi C, Scadding GK, Scadding G.Chronic Rhinosinusitis-Could Phenotyping or EndotypingAid Therapy? Am J Rhinol Allergy. 2019;33(1):83-93. doi:10.1177/1945892418807590

  21. Soler ZM, Schlosser RJ, Bodner TE, Alt JA, RamakrishnanVR, Mattos JL, et al. Endotyping chronic rhinosinusitis basedon olfactory cleft mucus biomarkers. J Allergy Clin Immunol.2021;147(5):1732-1741.e1. doi: 10.1016/j.jaci.2021.01.021

  22. Carroll Patiño MP, Silva R. Eosinofilia periférica comofactor de severidad tomográfica en rinosinusitis crónica. ActaOtorrinolaringol Cir Cabeza Cuello. 2020;48(2):142-9. doi:10.37076/acorl.v48i2.533

  23. Younis RT, Anand VK, Davidson B. The role of computedtomography and magnetic resonance imaging in patients withsinusitis with complications. Laryngoscope. 2002;112(2):224-9. doi: 10.1097/00005537-200202000-00005

  24. Wu AW, Borrelli M, Raskin J, Hopp ML, Mirocha J, Tang DM.Correlation of chronic rhinosinusitis-related symptoms withcomputed tomography subsite. Int Forum Allergy Rhinol. 2021.doi: 10.1002/alr.22920

  25. Gregurić T, Prokopakis E, Vlastos I, Doulaptsi M, Cingi C,Košec A, et al. Imaging in chronic rhinosinusitis: A systematicreview of MRI and CT diagnostic accuracy and reliability inseverity staging. J Neuroradiol. 2021;48(4):277-281. doi:10.1016/j.neurad.2021.01.010

  26. Lund VJ, Kennedy DW. Staging for rhinosinusitis. OtolaryngolHead Neck Surg. 1997;117(3 Pt 2):S35-40. doi: 10.1016/s0194-5998(97)70005-6

  27. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-MooreJ, Cox L, Khan DA, et al. The diagnosis and management ofrhinitis: an updated practice parameter. J Allergy Clin Immunol.2008;122(2 Suppl):S1-84. doi: 10.1016/j.jaci.2008.06.003

  28. Krauss K, Nazar R, Naser A, Cabrera N. Patología unilateralde senos paranasales con compromiso predominante de unseno. Descripción de serie de casos. Rev OtorrinolaringolCir Cabeza Cuello. 2016;76(2):193-200. doi: 10.4067/S0718-48162016000200007

  29. Xu Z, Luo X, Xu L, Deng J, Gao W, Jiang L, et al. Effectof short-course glucocorticoid application on patients withchronic rhinosinusitis with nasal polyps. World Allergy OrganJ. 2020;13(6):100131. doi: 10.1016/j.waojou.2020.100131

  30. Head K, Chong L, Hopkins C, Philpott C, Schilder AGM, BurtonMJ. Corticosteroides orales a corto plazo además de otrostratamientos para la rinosinusitis crónica [Internet]. Cochrane;2016 [Acceso 2021]. Disponible en: https://www.cochrane.org/es/CD011992/ENT_corticosteroides-orales-corto-plazoademas-de-otros-tratamientos-para-la-rinosinusitis-cronica

  31. Andrews PJ, Poirrier AL, Lund VJ, Choi D. Outcomes inendoscopic sinus surgery: olfaction, nose scale and qualityof life in a prospective cohort study. Clin Otolaryngol.2016;41(6):798-803. doi: 10.1111/coa.12665

  32. Patel GB, Peters AT. The Role of Biologics in ChronicRhinosinusitis With Nasal Polyps. Ear Nose Throat J.2021;100(1):44-47. doi: 10.1177/0145561320964653

  33. Thamboo A, Kilty S, Witterick I, Chan Y, Chin CJ, Janjua A, etal. Canadian Rhinology Working Group consensus statement:biologic therapies for chronic rhinosinusitis. J OtolaryngolHead Neck Surg. 2021;50(1):15. doi: 10.1186/s40463-021-00493-2

  34. Bachert C, Zhang N, Cavaliere C, Weiping W, Gevaert E,Krysko O. Biologics for chronic rhinosinusitis with nasalpolyps. J Allergy Clin Immunol. 2020;145(3):725-739. doi:10.1016/j.jaci.2020.01.020

  35. Ghogomu N, Kern R. Chronic rhinosinusitis: the rationale forcurrent treatments. Expert Rev Clin Immunol. 2017;13(3):259-270. doi: 10.1080/1744666X.2016.1220833




2020     |     www.medigraphic.com